The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case
Abstract
Thyroid transcription factor 1 (NKX2-1/TITF1) mutations cause brain-lung-thyroid syndrome, characterized by congenital hypothyroidism (CH), infant respiratory distress syndrome (IRDS) and benign hereditary chorea (BHC). The objectives of the present study were (i) detection of NKX2-1 mutations in patients with CH associated with pneumopathy and/or BHC, (ii) functional analysis of new mutations in vitro and (iii) description of the phenotypic spectrum of brain-lung-thyroid syndrome. We identified three new heterozygous missense mutations (L176V, P202L, Q210P), a splice site mutation (376-2A-->G), and one deletion of NKX2-1 at 14q13. Functional analysis of the three missense mutations revealed loss of transactivation capacity on the human thyroglobulin enhancer/promoter. Interestingly, we showed that deficient transcriptional activity of NKX2-1-P202L was completely rescued by cotransfected PAX8-WT, whereas the synergistic effect was abolished by L176V and Q210P. The clinical spectrum of 6 own and 40 published patients with NKX2-1 mutations ranged from the complete triad of brain-lung-thyroid syndrome (50%), brain and thyroid disease (30%), to isolated BHC (13%). Thyroid morphology was normal (55%) and compensated hypothyroidism occurred in 61%. Lung disease occurred in 54% of patients (IRDS at term 76%; recurrent pulmonary infections 24%). On follow-up, 20% developed severe chronic interstitial lung disease, and 16% died. In conclusion, we describe five new NKX2.1 mutations with, for the first time, complete rescue by PAX8 of the deficient transactivating capacity in one case. Additionally, our review shows that the majority of affected patients display neurological and/or thyroidal problems and that, although less frequent, lung disease is responsible for a considerable mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The requirement of Nkx2-1 in the temporal specification of cortical interneuron subtypes
Butt, S. J. B., Sousa, V. H., Fuccillo, M. V., Hjerling-Leffler, J., Miyoshi, G., Kimura, S., & Fishell, G. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.031 · Cited by 330
Devriendt, K., Vanhole, C., Matthijs, G., & de Zegher, F. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381817 · Cited by 263
Nóbrega-Pereira, S., Kessaris, N., Du, T., Kimura, S., Anderson, S. A., & Marín, O. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.024 · Cited by 256 · cited 1×
“In the brain, NKX2-1 is specifically expressed in neurons of the hypothalamus (16,17) and is involved in interneuron specification and migration during forebrain development (18,19).”
BackgroundCastanet, M., Polak, M., Bonaïti-Pellié, C., Lyonnet, S., Czernichow, P., & Léger, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7501 · Cited by 240
Self-citationOlivieri, A., Stazi, M. A., Mastroiacovo, P., Fazzini, C., Medda, E., Spagnolo, A., De Angelis, S., Grandolfo, M. E., Taruscio, D., Cordeddu, V., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8235 · Cited by 224
Devos, H., Rodd, C., Gagné, N., Laframboise, R., & Van Vliet, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5831 · Cited by 204
Perry, R., Heinrichs, C., Bourdoux, P., Khoury, K., Szöts, F., Dussault, J. H., Vassart, G., & Van Vliet, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011995 · Cited by 167
Di Palma, T., Nitsch, R., Mascia, A., Nitsch, L., Di Lauro, R., & Zannini, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205977200 · Cited by 138 · cited 2×
“Thyrocyte specific target genes of NKX2-1 as Tg, and Tpo are transactivated in synergy with PAX8 (6,7).”
BackgroundGruschus, J. M., Tsao, D. H. H., Wang, L.-H., Nirenberg, M., & Ferretti, J. A. (1997) · Biochemistry · doi:10.1021/bi9620060 · Cited by 76
Dentice, M., Luongo, C., Elefante, A., Ambrosio, R., Salzano, S., Zannini, M., Nitsch, R., Di Lauro, R., Rossi, G., Fenzi, G., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10171-10182.2005 · Cited by 48
Cited by
In vitro generation of human pluripotent stem cell derived lung organoids
Dye, B. R., Hill, D. R., Ferguson, M. A., Tsai, Y.-H., Nagy, M. S., Dyal, R., Wells, J. M., Mayhew, C. N., Nattiv, R., Klein, O. D., et al. (2015) · eLife · doi:10.7554/elife.05098 · Cited by 819
Lung development: orchestrating the generation and regeneration of a complex organ
Herriges, M., & Morrisey, E. E. (2014) · Development · doi:10.1242/dev.098186 · Cited by 613
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“Accurate genotyping/genetic testing of patients with CH by mutation analysis of candidate genes can or may (i) explain the disease; (ii) predict the risk of CH and extrathyroidal defects in family members (to be performed in all cases of syndromic primary CH, and in central CH); (iii) identify carriers of NKX2-1 gene…”
BackgroundSelf-citationKurland, G., Deterding, R. R., Hagood, J. S., Young, L. R., Brody, A. S., Castile, R. G., Dell, S., Fan, L. L., Hamvas, A., Hilman, B. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201305-0923st · Cited by 462
Warburton, D., El-Hashash, A., Carraro, G., Tiozzo, C., Sala, F., Rogers, O., Langhe, S. D., Kemp, P. J., Riccardi, D., Torday, J., et al. (2010) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)90003-3 · Cited by 421
Marras, C., Lang, A., van de Warrenburg, B. P., Sue, C. M., Tabrizi, S. J., Bertram, L., Mercimek‐Mahmutoglu, S., Ebrahimi‐Fakhari, D., Warner, T. T., Durr, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26527 · Cited by 285
Thyroid transcription factors in development, differentiation and disease
Fernández, L. P., López-Márquez, A., & Santisteban, P. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.186 · Cited by 258
DIAGNOSIS OF ENDOCRINE DISEASE: Congenital hypothyroidism: update and perspectives
Peters, C., van Trotsenburg, A. S. P., & Schoenmakers, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0383 · Cited by 162
Clinical Genetics of Congenital Hypothyroidism
Szinnai, G. (2014) · Endocrine Development · doi:10.1159/000363156 · Cited by 115
Self-citationThorwarth, A., Schnittert-Hübener, S., Schrumpf, P., Müller, I., Jyrch, S., Dame, C., Biebermann, H., Kleinau, G., Katchanov, J., Schuelke, M., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102248 · Cited by 115
Genetics and management of congenital hypothyroidism
Persani, L., Rurale, G., de Filippis, T., Galazzi, E., Muzza, M., & Fugazzola, L. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.05.002 · Cited by 82
TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology
Stoupa, A., Adam, F., Kariyawasam, D., Strassel, C., Gawade, S., Szinnai, G., Kauskot, A., Lasne, D., Janke, C., Natarajan, K., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809569 · Cited by 71
“…covering a wide clinical spectrum identified mutations in nine genes: PAX8, NKX2-1, FOXE1, NKX2-5, TSHR, GLIS3, NTN1, JAG1 and BOREALIN (Dentice et al, 2006; Senée et al, 2006; Carré et al, 2009, 2014, 2017; Sura-Trueba et al, 2009; Ramos et al, 2014; Opitz et al, 2015; de Filippis et al, 2016).”
BackgroundSelf-citationUpdate of Thyroid Developmental Genes
Stoupa, A., Kariyawasam, D., Carré, A., & Polak, M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.01.007 · Cited by 47
Self-citationDisorders of thyroid morphogenesis
Abu-Khudir, R., Larrivée-Vanier, S., Wasserman, J. D., & Deladoëy, J. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.04.008 · Cited by 46
Azar-Kolakez, A., Ecosse, E., Dos Santos, S., & Léger, J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2731 · Cited by 27
“However, none of our patients displayed the known “brain-lung-thyroid syndrome” with either the complete triad or brain-thyroid syndrome only; these 2 conditions include neurologic symptoms, such as benign hereditary chorea, hypotonia, and psychomotor delay, caused by NKX2–1 mutations, which have been shown to disrupt…”
BackgroundSelf-citation
Metadata
- Authors
- Carre, A., Szinnai, G., Castanet, M., Sura-Trueba, S., Tron, E., Broutin-L'Hermite, I., Barat, P., Goizet, C., Lacombe, D., Moutard, M.-L., Raybaud, C., Raynaud-Ravni, C., Romana, S., Ythier, H., Leger, J., & Polak, M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-31
- Volume
- 18
- Issue
- 12
- Pages
- 2266-2276
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2096374604
- Cited by
- 212
- References
- 10
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.